Dividend Timetable Amendment

RNS Number : 9573Y

EKF Diagnostics Holdings PLC

14 September 2020

 

EKF Diagnostics Holdings plc

("EKF", the "Company" or the "Group")

Dividend Timetable Amendment

Further to the interim results announcement released this morning, the dividend timetable should be amended to refer to the following key dates:

Ex-dividend date:	5 November 2020
Record date:	6 November 2020
Payment date:	1 December 2020

EKF Diagnostics Holdings plc		www.ekfdiagnostics.com
Christopher Mills, Non-executive Chairman		Tel: [phone]
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer		Tel: [phone]
Aubrey Powell / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Lianne Cawthorne	Mob: [phone]

About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com )

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

 

END

 

 

FURGPUMUBUPUGMC